For the quarter ending 2026-01-31, VNOV made $709,625 in revenue. -$44,362 in net income. Net profit margin of -6.25%.
| Income Statement | 2026-01-31 | |||
|---|---|---|---|---|
| Revenue, net | 709,625 | |||
| Cost of revenue | 393,282 | |||
| Gross profit | 316,343 | |||
| Sales and distribution expenses | 0 | |||
| Personnel and benefit costs | 50,012 | |||
| General and administrative expenses | 219,600 | |||
| Total operating expenses | 269,612 | |||
| Income from operations | 46,731 | |||
| Other income | 0 | |||
| Interest expenses | 0 | |||
| Total other expenses, net | 0 | |||
| Income before income tax | 46,731 | |||
| Income tax expense | 91,093 | |||
| Net (loss) income | -44,362 | |||
| Basic EPS | -0.01 | |||
| Diluted EPS | -0.01 | |||
| Basic Average Shares | 8,337,454 | |||
| Diluted Average Shares | 8,337,454 | |||
VitaNova Life Sciences Corp (VNOV)
VitaNova Life Sciences Corp (VNOV)